Humacyte Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.55

-0.01 (-1.81%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +2,681.4% upside

Low Target $10.64

Average Target $15.22

High Target $24.41

Current Price $0.55

Current
$0.55

Target
$15.22

$10.64 $15.22 avg $24.41

Scenario Analysis

Bear Case

$10.64

1,844.4%

Low target

Base Case

$15.22

+2,681.4%

Avg target

Bull Case

$24.41

+4,360.9%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$2.55

-78.5% from high

52-Week Low

$0.53

+4.0% from low

Target vs 52W High

$15.22

+496.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%